Cutler Group LP Agios Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 07, 2023	SELL	$24.81 - $31.52 $99,240 - $126,080	-4,000 Reduced 50.0%	4,000 $6,000
Q3 2022 Oct 25, 2022	BUY	$19.51 - $34.14 $78,040 - $136,560	4,000 Added 100.0%	8,000 $44,000
Q2 2022 Aug 04, 2022	BUY	$17.06 - $31.42 $64,827 - $119,396	3,800 Added 1900.0%	4,000 $14,000
Q1 2022 Apr 14, 2022	SELL	$26.68 - $34.81 $266,800 - $348,100	-10,000 Reduced 98.04%	200 $0
Q1 2021 Apr 26, 2021	BUY	$44.23 - $57.5 $340,571 - $442,750	7,700 Added 308.0%	10,200 $24,000
Q4 2020 Jan 21, 2021	SELL	$33.21 - $46.54 $255,717 - $358,358	-7,700 Reduced 75.49%	2,500 $4,000
Q1 2020 May 07, 2020	BUY	$31.52 - $53.81 $312,048 - $532,719	9,900 Added 3300.0%	10,200 $40,000
Q4 2019 Feb 06, 2020	SELL	$30.08 - $50.59 $385,024 - $647,552	-12,800 Reduced 97.71%	300 $2,000
Q4 2018 Feb 05, 2019	BUY	$42.73 - $76.53 $427,299 - $765,300	10,000 Added 322.58%	13,100 $0
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $7,322 - $9,955	100 Added 3.33%	3,100 $37,000
Q1 2018 May 11, 2018	BUY	$59.83 - $86.53 $95,728 - $138,448	1,600 Added 114.29%	3,000 $41,000
Q4 2017 Jan 17, 2018	SELL	$52.12 - $72.33 $151,148 - $209,757	-2,900 Reduced 67.44%	1,400 $0
Q3 2017 Oct 17, 2017	BUY	$54.89 - $67.12 $236,027 - $288,616	4,300	4,300 $29,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.87B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.